Annual Operating Expenses
$21.43 M
-$150.00 K-0.70%
31 December 2023
Summary:
Theriva Biologics annual total operating expenses is currently $21.43 million, with the most recent change of -$150.00 thousand (-0.70%) on 31 December 2023. During the last 3 years, it has risen by +$11.27 million (+110.94%). TOVX annual operating expenses is now -47.70% below its all-time high of $40.98 million, reached on 01 December 2015.TOVX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$5.04 M
+$616.00 K+13.94%
01 September 2024
Summary:
Theriva Biologics quarterly total operating expenses is currently $5.04 million, with the most recent change of +$616.00 thousand (+13.94%) on 01 September 2024. Over the past year, it has increased by +$818.00 thousand (+19.39%). TOVX quarterly operating expenses is now -57.63% below its all-time high of $11.89 million, reached on 01 December 2012.TOVX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TOVX Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.7% | +19.4% |
| 3 y3 years | +110.9% | -4.3% |
| 5 y5 years | +36.8% | +56.9% |
TOVX Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -0.7% | +110.9% | -31.2% | +19.4% |
| 5 y | 5 years | -0.7% | +110.9% | -31.2% | +138.6% |
| alltime | all time | -47.7% | +1524.5% | -57.6% | +1578.7% |
Theriva Biologics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $5.04 M(+13.9%) |
| June 2024 | - | $4.42 M(-18.0%) |
| Mar 2024 | - | $5.39 M(-13.3%) |
| Dec 2023 | $21.43 M(-0.7%) | $6.22 M(+47.4%) |
| Sept 2023 | - | $4.22 M(-27.5%) |
| June 2023 | - | $5.82 M(+12.4%) |
| Mar 2023 | - | $5.18 M(-29.2%) |
| Dec 2022 | $21.58 M(+51.2%) | $7.32 M(+46.8%) |
| Sept 2022 | - | $4.99 M(-0.8%) |
| June 2022 | - | $5.03 M(+18.2%) |
| Mar 2022 | - | $4.25 M(-19.2%) |
| Dec 2021 | $14.27 M(+40.5%) | - |
| Dec 2021 | - | $5.26 M(+60.8%) |
| Sept 2021 | - | $3.27 M(+2.4%) |
| June 2021 | - | $3.20 M(+26.0%) |
| Mar 2021 | - | $2.54 M(+19.0%) |
| Dec 2020 | $10.16 M(-35.1%) | $2.13 M(+1.0%) |
| Sept 2020 | - | $2.11 M(-26.9%) |
| June 2020 | - | $2.89 M(-4.6%) |
| Mar 2020 | - | $3.03 M(-5.7%) |
| Dec 2019 | $15.66 M(-10.9%) | $3.21 M(-38.8%) |
| Sept 2019 | - | $5.24 M(+44.1%) |
| June 2019 | - | $3.64 M(+1.8%) |
| Mar 2019 | - | $3.57 M(+9.6%) |
| Dec 2018 | $17.57 M(-33.1%) | $3.26 M(-24.6%) |
| Sept 2018 | - | $4.32 M(-13.7%) |
| June 2018 | - | $5.00 M(+0.3%) |
| Mar 2018 | - | $4.99 M(-13.7%) |
| Dec 2017 | $26.25 M(-33.1%) | $5.78 M(-1.0%) |
| Sept 2017 | - | $5.84 M(-9.8%) |
| June 2017 | - | $6.47 M(-20.5%) |
| Mar 2017 | - | $8.15 M(-20.1%) |
| Dec 2016 | $39.25 M(-4.2%) | $10.20 M(+11.4%) |
| Sept 2016 | - | $9.16 M(-1.7%) |
| June 2016 | - | $9.31 M(-12.0%) |
| Mar 2016 | - | $10.58 M(-7.1%) |
| Dec 2015 | $40.98 M(+99.9%) | $11.39 M(-2.2%) |
| Sept 2015 | - | $11.65 M(+19.7%) |
| June 2015 | - | $9.73 M(+18.6%) |
| Mar 2015 | - | $8.21 M(+15.6%) |
| Dec 2014 | $20.50 M(+66.2%) | $7.10 M(+44.6%) |
| Sept 2014 | - | $4.91 M(+5.6%) |
| June 2014 | - | $4.65 M(+21.2%) |
| Mar 2014 | - | $3.84 M(-10.2%) |
| Dec 2013 | $12.34 M(-28.7%) | $4.27 M(+27.0%) |
| Sept 2013 | - | $3.37 M(+36.7%) |
| June 2013 | - | $2.46 M(+9.9%) |
| Mar 2013 | - | $2.24 M(-81.2%) |
| Dec 2012 | $17.30 M(+191.8%) | $11.89 M(+547.4%) |
| Sept 2012 | - | $1.84 M(+6.6%) |
| June 2012 | - | $1.72 M(-7.1%) |
| Mar 2012 | - | $1.85 M(-33.5%) |
| Dec 2011 | $5.93 M(+60.3%) | $2.79 M(+220.1%) |
| Sept 2011 | - | $871.00 K(+8.2%) |
| June 2011 | - | $805.00 K(-45.0%) |
| Mar 2011 | - | $1.46 M(+99.5%) |
| Dec 2010 | $3.70 M | $734.00 K(-11.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | $830.80 K(-23.7%) |
| June 2010 | - | $1.09 M(+3.8%) |
| Mar 2010 | - | $1.05 M(+6.4%) |
| Dec 2009 | $3.66 M(-50.0%) | $986.10 K(+45.6%) |
| Sept 2009 | - | $677.30 K(-23.0%) |
| June 2009 | - | $879.60 K(-19.3%) |
| Mar 2009 | - | $1.09 M(+18.4%) |
| Dec 2008 | $7.32 M(-27.8%) | $920.10 K(-37.4%) |
| Sept 2008 | - | $1.47 M(-18.4%) |
| June 2008 | - | $1.80 M(-42.4%) |
| Mar 2008 | - | $3.13 M(-2.8%) |
| Dec 2007 | $10.14 M(+147.0%) | $3.22 M(+48.0%) |
| Sept 2007 | - | $2.17 M(+18.9%) |
| June 2007 | - | $1.83 M(-37.4%) |
| Mar 2007 | - | $2.92 M(+38.1%) |
| Dec 2006 | $4.10 M(+211.1%) | $2.12 M(+179.2%) |
| Sept 2006 | - | $757.60 K(+5.8%) |
| June 2006 | - | $716.20 K(+38.9%) |
| Mar 2006 | - | $515.50 K(-24.1%) |
| Dec 2005 | $1.32 M(-84.0%) | - |
| Mar 2003 | - | $679.40 K(-19.6%) |
| Dec 2002 | $8.26 M(-22.7%) | $845.20 K(-28.2%) |
| Sept 2002 | - | $1.18 M(-62.1%) |
| June 2002 | - | $3.10 M(-0.9%) |
| Mar 2002 | - | $3.13 M(+4.0%) |
| Dec 2001 | $10.68 M(+59.8%) | $3.01 M(+9.4%) |
| Sept 2001 | - | $2.75 M(-10.9%) |
| June 2001 | - | $3.09 M(-71.4%) |
| Mar 2001 | - | $10.79 M(+438.6%) |
| Dec 2000 | $6.68 M(+15.5%) | $2.00 M(+38.4%) |
| Sept 2000 | - | $1.45 M(-10.0%) |
| June 2000 | - | $1.61 M(-1.3%) |
| Mar 2000 | - | $1.63 M(-3.4%) |
| Dec 1999 | $5.79 M(+5.2%) | $1.69 M(+12.3%) |
| Sept 1999 | - | $1.50 M(+7.1%) |
| June 1999 | - | $1.40 M(+16.6%) |
| Mar 1999 | - | $1.20 M(+20.1%) |
| Dec 1998 | $5.50 M(-34.5%) | $1.00 M(-16.7%) |
| Sept 1998 | - | $1.20 M(+9.1%) |
| June 1998 | - | $1.10 M(-50.0%) |
| Mar 1998 | - | $2.20 M(+633.3%) |
| Dec 1997 | $8.40 M(+7.7%) | $300.00 K(-84.2%) |
| Sept 1997 | - | $1.90 M(-44.1%) |
| June 1997 | - | $3.40 M(+25.9%) |
| Mar 1997 | - | $2.70 M(+22.7%) |
| Dec 1996 | $7.80 M(+5.4%) | $2.20 M(0.0%) |
| Sept 1996 | - | $2.20 M(+29.4%) |
| June 1996 | - | $1.70 M(0.0%) |
| Mar 1996 | - | $1.70 M(-10.5%) |
| Dec 1995 | $7.40 M(+15.6%) | $1.90 M(-9.5%) |
| Sept 1995 | - | $2.10 M(+425.0%) |
| Dec 1994 | $6.40 M(+73.0%) | - |
| Mar 1994 | - | $400.00 K(-63.6%) |
| Dec 1993 | $3.70 M | $1.10 M(-26.7%) |
| Sept 1993 | - | $1.50 M(+200.0%) |
| June 1993 | - | $500.00 K(+25.0%) |
| Mar 1993 | - | $400.00 K |
FAQ
- What is Theriva Biologics annual total operating expenses?
- What is the all time high annual operating expenses for Theriva Biologics?
- What is Theriva Biologics annual operating expenses year-on-year change?
- What is Theriva Biologics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Theriva Biologics?
- What is Theriva Biologics quarterly operating expenses year-on-year change?
What is Theriva Biologics annual total operating expenses?
The current annual operating expenses of TOVX is $21.43 M
What is the all time high annual operating expenses for Theriva Biologics?
Theriva Biologics all-time high annual total operating expenses is $40.98 M
What is Theriva Biologics annual operating expenses year-on-year change?
Over the past year, TOVX annual total operating expenses has changed by -$150.00 K (-0.70%)
What is Theriva Biologics quarterly total operating expenses?
The current quarterly operating expenses of TOVX is $5.04 M
What is the all time high quarterly operating expenses for Theriva Biologics?
Theriva Biologics all-time high quarterly total operating expenses is $11.89 M
What is Theriva Biologics quarterly operating expenses year-on-year change?
Over the past year, TOVX quarterly total operating expenses has changed by +$818.00 K (+19.39%)